STOCK TITAN

Quanterix Financials

QTRX
FY2025 annual
Revenue $138.9M +1.1% YoY
Net Income -$107.2M -178.4% YoY
EPS (Diluted) -$2.51 -151.0% YoY
Free Cash Flow -$79.8M -107.2% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Quanterix (QTRX) reported $138.9M in revenue for fiscal year 2025, up 1.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QTRX FY2025

Flat sales met a higher-cost structure, leaving FY2025 defined by margin collapse and a much faster drain on cash.

FY2025's cash squeeze was not just a deeper accounting loss: operating cash outflow widened to -$77.2M while investing cash flow turned positive at $50.2M. Even with that support from investing activity, cash still ended at $29.8M, showing the core business is now the main driver of liquidity pressure rather than capital spending.

After two years near 60% gross margin, FY2025 fell to 46.8%, so the setback was not a demand story alone; each revenue dollar carried materially less gross profit before overhead. Because SG&A and R&D also moved higher, the company lost what little operating leverage it had and drifted farther from break-even despite essentially flat sales.

The balance sheet also became less forgiving: inventory rose to $54.8M while cash fell to $29.8M. The current ratio dropped from 8.7x to 2.8x in one year, which still signals near-term coverage but far less cushion if working capital keeps absorbing cash at this pace.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 25 / 100
Financial Health Score 25/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Quanterix's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
0

Not available for Quanterix, and counted as zero in the overall score.

Dilution
45
R&D Intensity
42
Revenue Progress
57
Burn Trend
6
Balance Sheet
0

Not available for Quanterix, and counted as zero in the overall score.

Altman Z-Score Distress
-1.55

Quanterix scores -1.55, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($131.9M) relative to total liabilities ($123.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
1/8

Quanterix passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Quanterix reported a net loss of $107.2M while operations used $77.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Quanterix reported an operating loss of $125.5M against $8.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$138.9M
YoY+1.1%
5Y CAGR+10.0%

Quanterix generated $138.9M in revenue in fiscal year 2025. This represents an increase of 1.1% from the prior year.

EBITDA
-$109.7M
YoY-137.7%

Quanterix's EBITDA was -$109.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 137.7% from the prior year.

Net Income
-$107.2M
YoY-178.4%

Quanterix reported -$107.2M in net income in fiscal year 2025. This represents a decrease of 178.4% from the prior year.

EPS (Diluted)
-$2.51
YoY-151.0%

Quanterix earned -$2.51 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 151.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$79.8M
YoY-107.2%

Quanterix recorded an outflow of $79.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 107.2% from the prior year.

Cash & Debt
$29.8M
YoY-47.4%
5Y CAGR-30.3%

Quanterix held $29.8M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
47M
YoY+21.3%
5Y CAGR+8.0%

Quanterix had 47M shares outstanding in fiscal year 2025. This represents an increase of 21.3% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
46.8%
YoY-13.7pp
5Y CAGR-9.0pp

Quanterix's gross margin was 46.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 13.7 percentage points from the prior year.

Operating Margin
-90.4%
YoY-52.1pp
5Y CAGR-53.8pp

Quanterix's operating margin was -90.4% in fiscal year 2025, reflecting core business profitability. This is down 52.1 percentage points from the prior year.

Net Margin
-77.2%
YoY-49.2pp
5Y CAGR-40.7pp

Quanterix's net profit margin was -77.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 49.2 percentage points from the prior year.

Return on Equity
-36.3%
YoY-24.6pp
5Y CAGR-20.9pp

Quanterix's ROE was -36.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 24.6 percentage points from the prior year.

Capital Allocation

R&D Spending
$35.9M
YoY+15.6%
5Y CAGR+12.2%

Quanterix invested $35.9M in research and development in fiscal year 2025. This represents an increase of 15.6% from the prior year.

Capital Expenditures
$2.6M
YoY-22.4%
5Y CAGR-7.8%

Quanterix invested $2.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 22.4% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

QTRX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

QTRX annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16
Revenue$153.4M$138.9M+1.1%$137.4M+12.3%$122.4M+16.0%$105.5M-4.6%$110.6M+28.0%$86.4M+52.2%$56.7M+50.8%$37.6M+64.5%$22.9M+30.1%$17.6M
Cost of Revenue$85.0M$73.9M+36.1%$54.3M+12.8%$48.1M-20.0%$60.2M+31.4%$45.8M+19.9%$38.2M+27.8%$29.9M+51.9%$19.7M+52.7%$12.9M+31.0%$9.8M
Gross Profit$68.4M$65.0M-21.8%$83.1M+12.0%$74.2M+63.6%$45.4M-30.0%$64.8M+34.4%$48.2M+79.5%$26.8M+49.5%$17.9M+79.7%$10.0M+28.9%$7.7M
R&D Expenses$31.9M$35.9M+15.6%$31.1M+19.3%$26.1M-2.8%$26.8M-5.5%$28.4M+40.7%$20.2M+24.6%$16.2M+2.4%$15.8M-3.1%$16.3M-4.1%$17.0M
SG&A Expenses$133.6M$138.0M+35.8%$101.6M+14.0%$89.1M-3.0%$91.9M-1.1%$92.9M+55.9%$59.6M+14.1%$52.2M+55.1%$33.7M+71.1%$19.7M+57.9%$12.5M
Operating Income-$152.9M-$125.5M-138.6%-$52.6M-14.4%-$46.0M+55.9%-$104.3M-84.5%-$56.5M-79.0%-$31.6M+24.1%-$41.6M-31.9%-$31.6M-21.3%-$26.0M-19.8%-$21.7M
Interest ExpenseN/A$8.6M-41.5%$14.7M-7.5%$15.8M+208.7%$5.1M+1373.2%-$403K-47.6%-$273K-143.5%$627K+1263.0%$46K+104.8%-$951K+26.7%-$1.3M
Income Tax-$2.2M-$5.1M-1280.0%$434K-39.6%$719K+338.4%$164K+555.6%-$36K+90.4%-$376K-101.1%-$187K-848.0%$25K$0N/A
Net Income-$123.2M-$107.2M-178.4%-$38.5M-35.6%-$28.4M+71.5%-$99.6M-79.5%-$55.5M-76.0%-$31.5M+22.7%-$40.8M-29.4%-$31.5M-16.7%-$27.0M-16.6%-$23.2M
EPS (Diluted)-$2.51-151.0%-$1.00-33.3%-$0.75+72.1%-$2.69-74.7%-$1.54-43.9%-$1.07+34.4%-$1.63N/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

QTRX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

QTRX annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16
Total Assets$418.8M+3.0%$406.5M-5.1%$428.6M-1.2%$433.6M-13.5%$501.5M+85.0%$271.0M+59.5%$170.0M+151.4%$67.6M-26.3%$91.8MN/A
Current Assets$212.3M-41.6%$363.6M-4.8%$382.1M+0.1%$381.5M-15.0%$449.0M+104.4%$219.6M+65.5%$132.7M+123.0%$59.5M-33.3%$89.3MN/A
Cash & Equivalents$29.8M-47.4%$56.7M-67.5%$174.4M-48.5%$338.7M-14.6%$396.5M+118.3%$181.6M+66.4%$109.2M+145.7%$44.4M-44.2%$79.7M+168.6%$29.7M
Inventory$54.8M+67.1%$32.8M+25.5%$26.1M+54.0%$17.0M-23.6%$22.2M+49.4%$14.9M+42.0%$10.5M+76.0%$5.9M+66.5%$3.6MN/A
Accounts Receivable$30.0M-6.7%$32.1M+26.5%$25.4M+33.6%$19.0M-20.0%$23.8M+38.4%$17.2M+57.6%$10.9M+60.6%$6.8M+21.3%$5.6MN/A
Goodwill$26.4M$0$0$0-100.0%$9.6M-7.9%$10.5M+11.8%$9.4M+615.1%$1.3MN/AN/A
Total Liabilities$123.0M+60.8%$76.5M-2.7%$78.6M+3.9%$75.7M+24.9%$60.6M-6.7%$64.9M+57.2%$41.3M+55.6%$26.5M+2.4%$25.9MN/A
Current Liabilities$74.8M+78.0%$42.0M+7.8%$39.0M+24.3%$31.3M-15.2%$37.0M-7.1%$39.8M+100.7%$19.8M+9.4%$18.1M-8.1%$19.7MN/A
Long-Term DebtN/AN/AN/AN/AN/A$7.7M+1.3%$7.6M-0.5%$7.6M+75.4%$4.3MN/A
Total Equity$295.7M-10.4%$330.0M-5.7%$350.0M-2.2%$357.9M-19.2%$442.8M+115.1%$205.8M+60.0%$128.7M+213.3%$41.1M-37.7%$65.9M+157.2%-$115.1M
Retained Earnings-$577.2M-22.8%-$470.1M-8.9%-$431.6M-7.0%-$403.2M-32.0%-$305.5M-23.3%-$247.8M-14.6%-$216.2M-22.9%-$175.9M-21.8%-$144.4MN/A

QTRX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

QTRX annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16
Operating Cash Flow-$80.9M-$77.2M-119.6%-$35.2M-86.6%-$18.8M+61.2%-$48.6M-2.1%-$47.6M-103.8%-$23.4M+10.8%-$26.2M+8.8%-$28.7M-29.9%-$22.1M-24.6%-$17.7M
Capital Expenditures$762K$2.6M-22.4%$3.4M-12.3%$3.8M-66.9%$11.6M-15.1%$13.7M+248.0%$3.9M-63.8%$10.8M+614.6%$1.5M+34.1%$1.1M+115.2%$526K
Free Cash Flow-$81.9M-$79.8M-107.2%-$38.5M-69.8%-$22.7M+62.3%-$60.2M+1.7%-$61.3M-124.6%-$27.3M+26.3%-$37.0M-22.5%-$30.2M-30.1%-$23.2M-27.2%-$18.3M
Investing Cash Flow-$5.5M$50.2M+161.1%-$82.3M+44.6%-$148.5M-1238.1%-$11.1M-73.4%-$6.4M-921.9%-$626K+97.5%-$25.4M-365.3%-$5.5M-381.8%-$1.1M-37.0%-$826K
Financing Cash Flow-$1.7M-$708K-255.3%$456K-83.1%$2.7M+16.4%$2.3M-99.1%$270.8M+181.4%$96.2M-17.2%$116.2M+149070.5%-$78K-100.1%$73.2M+59.5%$45.9M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

QTRX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

QTRX annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16
Gross Margin46.8%-13.7pp60.5%-0.2pp60.7%+17.7pp43.0%-15.6pp58.6%+2.8pp55.8%+8.5pp47.3%-0.4pp47.7%+4.0pp43.7%-0.4pp44.1%
Operating Margin-90.4%-52.1pp-38.3%-0.7pp-37.6%+61.2pp-98.8%-47.7pp-51.1%-14.5pp-36.6%+36.7pp-73.3%+10.5pp-83.8%-113.7%-123.5%
Net Margin-77.2%-49.2pp-28.0%-4.8pp-23.2%+71.2pp-94.4%-44.2pp-50.2%-13.7pp-36.5%+35.4pp-71.9%+11.9pp-83.8%-118.1%-131.8%
Return on Equity-36.3%-24.6pp-11.7%-3.6pp-8.1%+19.7pp-27.8%-15.3pp-12.5%+2.8pp-15.3%+16.4pp-31.7%+45.1pp-76.8%-35.8pp-41.0%N/A
Return on Assets-25.6%-16.1pp-9.5%-2.8pp-6.6%+16.3pp-23.0%-11.9pp-11.1%+0.6pp-11.6%+12.4pp-24.0%+22.6pp-46.6%-17.2pp-29.4%N/A
Current Ratio2.84-5.8x8.66-1.1x9.80-2.4x12.170.0x12.14+6.6x5.52-1.2x6.69+3.4x3.28-1.2x4.53N/A
Debt-to-Equity0.42+0.2x0.230.0x0.220.0x0.21+0.1x0.14+0.1x0.040.0x0.06-0.1x0.19+0.1x0.07N/A
FCF Margin-57.5%-29.4pp-28.0%-9.5pp-18.5%+38.5pp-57.1%-1.6pp-55.4%-23.8pp-31.6%+33.7pp-65.3%+15.1pp-80.3%-101.6%-103.9%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Quanterix's annual revenue?

Quanterix (QTRX) reported $138.9M in total revenue for fiscal year 2025. This represents a 1.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Quanterix's revenue growing?

Quanterix (QTRX) revenue grew by 1.1% year-over-year, from $137.4M to $138.9M in fiscal year 2025.

Is Quanterix profitable?

No, Quanterix (QTRX) reported a net income of -$107.2M in fiscal year 2025, with a net profit margin of -77.2%.

Quanterix (QTRX) reported diluted earnings per share of -$2.51 for fiscal year 2025. This represents a -151.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Quanterix (QTRX) had EBITDA of -$109.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Quanterix (QTRX) had a gross margin of 46.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Quanterix (QTRX) had an operating margin of -90.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Quanterix (QTRX) had a net profit margin of -77.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Quanterix (QTRX) has a return on equity of -36.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Quanterix (QTRX) recorded an outflow of $79.8M in free cash flow during fiscal year 2025. This represents a -107.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Quanterix (QTRX) recorded an outflow of $77.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Quanterix (QTRX) had $418.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Quanterix (QTRX) invested $2.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Quanterix (QTRX) invested $35.9M in research and development during fiscal year 2025.

Quanterix (QTRX) had 47M shares outstanding as of fiscal year 2025.

Quanterix (QTRX) had a current ratio of 2.84 as of fiscal year 2025, which is generally considered healthy.

Quanterix (QTRX) had a debt-to-equity ratio of 0.42 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Quanterix (QTRX) had a return on assets of -25.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Quanterix (QTRX) has an Altman Z-Score of -1.55, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Quanterix (QTRX) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Quanterix (QTRX) reported a net loss of $107.2M while operations used $77.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Quanterix (QTRX) reported an operating loss of $125.5M against $8.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Quanterix (QTRX) scores 25 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top